| Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 7523 | 2012 |
| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 2987 | 2017 |
| Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer S Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ... Nature 486 (7404), 532-536, 2012 | 2040 | 2012 |
| Clinical sequencing defines the genomic landscape of metastatic colorectal cancer R Yaeger, WK Chatila, MD Lipsyc, JF Hechtman, A Cercek, ... Cancer cell 33 (1), 125-136. e3, 2018 | 698 | 2018 |
| Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors S Yachida, E Vakiani, CM White, Y Zhong, T Saunders, R Morgan, ... The American journal of surgical pathology 36 (2), 173-184, 2012 | 543 | 2012 |
| Adoption of total neoadjuvant therapy for locally advanced rectal cancer A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ... JAMA oncology 4 (6), e180071-e180071, 2018 | 511 | 2018 |
| Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy JJ Smith, P Strombom, OS Chow, CS Roxburgh, P Lynn, A Eaton, ... JAMA oncology 5 (4), e185896-e185896, 2019 | 453 | 2019 |
| Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation LGT Morris, AM Kaufman, Y Gong, D Ramaswami, LA Walsh, Ş Turcan, ... Nature genetics 45 (3), 253-261, 2013 | 438 | 2013 |
| Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions AR Brannon, E Vakiani, BE Sylvester, SN Scott, G McDermott, RH Shah, ... Genome biology 15, 1-10, 2014 | 369 | 2014 |
| Genetic predictors of response to systemic therapy in esophagogastric cancer YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, ... Cancer discovery 8 (1), 49-58, 2018 | 329 | 2018 |
| Genomic and biological characterization of exon 4 KRAS mutations in human cancer M Janakiraman, E Vakiani, Z Zeng, CA Pratilas, BS Taylor, D Chitale, ... Cancer research 70 (14), 5901-5911, 2010 | 312 | 2010 |
| EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer V Amodio, R Yaeger, P Arcella, C Cancelliere, S Lamba, A Lorenzato, ... Cancer discovery 10 (8), 1129-1139, 2020 | 306 | 2020 |
| Comparative genomic analysis of primary versus metastatic colorectal carcinomas E Vakiani, M Janakiraman, R Shen, R Sinha, Z Zeng, J Shia, A Cercek, ... Journal of clinical oncology 30 (24), 2956-2962, 2012 | 306 | 2012 |
| Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients R Yaeger, A Cercek, EM O'Reilly, DL Reidy, N Kemeny, T Wolinsky, ... Clinical cancer research 21 (6), 1313-1320, 2015 | 293 | 2015 |
| Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases O Basturk, L Tang, RH Hruban, V Adsay, Z Yang, AM Krasinskas, ... The American journal of surgical pathology 38 (4), 437-447, 2014 | 264 | 2014 |
| KRAS and BRAF: drug targets and predictive biomarkers E Vakiani, DB Solit The Journal of pathology 223 (2), 220-230, 2011 | 242 | 2011 |
| BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer R Yaeger, A Cercek, JF Chou, BE Sylvester, NE Kemeny, JF Hechtman, ... Cancer 120 (15), 2316-2324, 2014 | 217 | 2014 |
| Schwann cells induce cancer cell dispersion and invasion S Deborde, T Omelchenko, A Lyubchik, Y Zhou, S He, WF McNamara, ... The Journal of clinical investigation 126 (4), 1538-1554, 2016 | 210 | 2016 |
| Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be … J Shia, LH Tang, E Vakiani, JG Guillem, ZK Stadler, RA Soslow, N Katabi, ... The American journal of surgical pathology 33 (11), 1639-1645, 2009 | 208 | 2009 |
| RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer R Yaeger, E Cowell, JF Chou, AN Gewirtz, L Borsu, E Vakiani, DB Solit, ... Cancer 121 (8), 1195-1203, 2015 | 193 | 2015 |
